Exemplis Discimus 2003, 147(2):185-191

Lorem ipsum dolor sit amet, consectetuer adipiscing elit.

Daran Frouda, Dawnshadow Atara, Alfredo Darrsta, Jazen Zorabosa, Miles Larbecb, Yveret Coocb, Ami Cynthisaa
a 1st Clinic of Nutrition and Biochemistry, Teaching Hospital of Utapah, Bogden Republic
b 2nd Clinic of Radiotherapy, Teaching Hospital of Abrion, Dagobah Republic

Vivamus ligula dolor, laoreet vulputate, rhoncus in, ullamcorper volutpat, erat. Vestibulum a arcu sit amet mauris scelerisque scelerisque. Curabitur vel orci vitae est iaculis congue. Vestibulum dolor magna, viverra at, scelerisque fringilla, imperdiet non, risus. Fusce vel nulla interdum est rutrum sodales. Morbi quis lectus at dolor dignissim consectetuer. Vestibulum nec quam vitae dui tincidunt iaculis.. Sed augue ligula, congue a, luctus in, viverra vehicula, nisi.

Kµúčové slová: Maecenas id metus, Nullam lectus, Nam augue, Proin ipsum, Integer est, Vestibulum sed nunc

Vloľený: September 28, 2003; Přijatý: November 7, 2003; Uverejnené: December 1, 2003 


Referencie

  1. Sulková Sylvie et al. (2000) Renální osteopatie, Hemodialýza, Maxdorf, Praha 21, 404-407.
  2. Torres, A, Rodriguez AP, Concepcion MT. (1998) Parathyroid function in long-term renal transplan patients. Nephrol Dial Transplant 13 (suppl 3), 94-97. Prejs» k pôvodnému zdroju...
  3. Torres A, Zarraga S, Rodriguez AP, Gomez Ullate P, Concepcion MT (1998) Optimum PTH levels before renal transplantation to prevent persistent hyperparatgyroidism. J Am Soc Nephrol 9, 572A.
  4. Yano S, Sugimoto T, Tuskamoto T. (2000) Association of decreased calcium-sensing receptor expression with proliferation of parathyroid cells in secondary hyperparathyroidism. Kidney Int 58, 1980-1986. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  5. UpToDate (2000), Citation: Parathroid and mineral metabolism after renal transplantation. Persistent hyperparathyroidsm and hypercalcemia.
  6. Moneir-Fraugere M-C, Geng Z, Maward H. (2001) Improved assessement of bone turnover by the PTH/large C-PTH fragments ratio in ESRD pacients. Kidney Int., 1460-1468. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  7. Casez JP. (2002) Changes in bone metabolism mineral density over 18 monthes follwing kidney transplantation: the respective roles of prednison and parathyroid hormon. Nephrol Dial Transplant 17, 1318-1326. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  8. Reinhardt W, Bartelworth H, Jokenhovel F, Shmiddt-Gayk H (1998). Sequential changes of biochemical bone parametrs after kidney transplantation. Nephrol Dial Transplant. 13, 436-442. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  9. Moshe L. (2001) Postr-transplant hypophosphatemia. Kidney Int., 2377-2387.
  10. Monegal A, Navasa A, Guanabens N. (2001) Bone disease after liver transplantation: along term prospective study of bone mass changes, hormonal status and histomorphometric characteristics. Osteoporosis Int. 12, 484-492. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  11. Reinhardt W, Bartelworth H, Jockenhovel F, Schmidt-Gayk H (1998). Sequential changes of biochemical bone parametrs after kidney transplantation. Nephrol Dial Transplant. 13, 436-442. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  12. Armando T, Lorenzo V and Salido E. (2002) Calcium Metabolism and Skeletal problems after Transplantation. Am Soscity Ne phrol 13, 551-558.
  13. Weinstein RS, Jilka RL, Parfi tt AM., Manolagas SC (1998). Inhibition of osteoclastogenesis and promotion of apoptosis of osteoblasts and osteoclasts by glucocorticoids, potencial mechanisms of their deleterious eff ects on bone. J Clin Invest 102, 274-282. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  14. Casez JP. (2002) Changes in bone metabolism mineral density over 18 monthes follwing kidney transplantation, the respective roles of prednison and parathyroid hormon. Nephrol Dial Transplant 17, 1318-1326. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  15. Weber TJ, Linka A, Quarles LD. (2000) Preventing bone loss after renal transplantation with bisphosphonates, We can but should we? Kidney Int 57, 735-737. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  16. Bianda T, Linka A, Junga, G. (2000) Prevention of osteoporosis in heart transplant recipeients, A comparison of calcitriol with calcitonin and pamidronate. Calcif Tissue Int 67, 116-121. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  17. Pichette V, Bonnardeaux Am, Prudhomme, L. (1996) Long term bone loss in kidney transplant recipients, A cross-sectional and longitudinal study. Am J Kidney Dis 28, 105-114. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  18. Sprague SM. (2000). Mechanism of transplantation- associated bone loss. Pediatr Nephrol 14, 650-653. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  19. Cayco AV, Wysolmerski J, Simpson, CH (2000). Post-transplant bone disease,evidence for a high bone resorption intake. Transplantation 70, 1722-1728. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  20. Thiébaud D, Krieg, Ma., Gillard- Beurger D.(1996) Cyclosporin induces high bone turover and may contribte to bone loss after heart transplantation. Europ J Clin Investig. 26, 549-555. Prejs» k pôvodnému zdroju... Prejs» na PubMed...
  21. Moneir-Faugers M-C, Mawad H. (2000). High prevalence of low bone turnover and occurrence of osteomalacia after kidney transplantation. J Am Soc Nephrol. 11, 1093-1099. Prejs» na PubMed...
  22. Dissanayker IR, Epstein S (1998). The fate of bone after renal transplantation.Cur open Nephrol Hypertention 7, 389-395. Prejs» k pôvodnému zdroju...
  23. Martins L, Quieros J, Ferreira A.(1991) Rapid loss of vertebral mineral density after renal transplantation. N Engl J Med 325, 2599-2601.